Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Other financing activities (2020 - 2025)

Historic Other financing activities for Exagen (XGN) over the last 3 years, with Q3 2025 value amounting to $199000.0.

  • Exagen's Other financing activities changed N/A to $199000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $869000.0, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2021, which is 2088571.43% up from last year.
  • Latest data reveals that Exagen reported Other financing activities of $199000.0 as of Q3 2025.
  • Over the past 5 years, Exagen's Other financing activities peaked at $4.2 million during Q1 2021, and registered a low of $65000.0 during Q1 2025.